Immunoreactive T and Tn antigens in malignancy: Role in carcinoma diagnosis, prognosis, and immunotherapy

被引：62

作者：

Desai, PR ^{[1
]}

机构：

[1] Finch Univ Hlth Sci Chicago Med Sch, Dept Microbiol & Immunol, HM Bligh Canc Res Labs, N Chicago, IL 60064 USA

来源：

关键词：

D O I：

10.1053/tmrv.2000.16229

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：312 / 325

页数：14

共 136 条

[1]

Aller CT, 1996, AM J HEMATOL, V52, P29, DOI 10.1002/(SICI)1096-8652(199605)52:1<29::AID-AJH5>3.0.CO

[2]

2-8

[3]

ALLER CT, 1993, J IMMUNOL, V150, pA143

ANGLIN, JH ;

LERNER, MP ;

NORDQUIST, RE .

[5] CELLULAR MUCINS - TARGETS FOR IMMUNOTHERAPY [J].

APOSTOLOPOULOS, V ;

MCKENZIE, IFC .

[6]

Avichezer D, 1997, INT J CANCER, V72, P119, DOI 10.1002/(SICI)1097-0215(19970703)72:1<119::AID-IJC17>3.3.CO

[7]

2-5

[8]

BARR N, 1989, CANCER-AM CANCER SOC, V64, P834, DOI 10.1002/1097-0142(19890815)64:4<834::AID-CNCR2820640413>3.0.CO

[9]

2-A

[10]

BEAHRS OH, 1992, MANUAL STAGING CANC, P6